abstract |
The present invention provides compounds of Formula (I) (see Formula) or a stereoisomer or a pharmaceutically acceptable salt thereof, wherein all the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors that can be used as medicines. |